Esperion Therapeutics
ESPR
#6155
Rank
S$1.16 B
Marketcap
S$4.91
Share price
4.11%
Change (1 day)
66.72%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: S$1.16 Billion

As of December 2025 Esperion Therapeutics has a market cap of S$1.16 Billion. This makes Esperion Therapeutics the world's 6155th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025S$1.16 B90.51%
2024S$0.61 B35.98%
2023S$0.44 B-27.03%
2022S$0.61 B49.49%
2021S$0.41 B-53.82%
2020S$0.89 B-59.68%
2019S$2.21 B31.14%
2018S$1.68 B-26.93%
2017S$2.30 B464.5%
2016S$0.40 B-42.36%
2015S$0.70 B-34.78%
2014S$1.08 B307.05%
2013S$0.26 B

End of Day market cap according to different sources

On Dec 18th, 2025 the market cap of Esperion Therapeutics was reported to be:

S$1.17 Billion
by Nasdaq info icon info icon
S$1.16 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
S$4.09 B 251.70%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$12.88 B 1,007.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$183.84 B 15,703.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$102.47 B 8,708.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$4.33 B 272.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
S$0.55 B-52.40%๐Ÿ‡บ๐Ÿ‡ธ USA